Stage III MSI-High Colorectal Adenocarcinoma: Briana's Survivor Story

Patient Info: Briana Ghbein, Under 40 | Stage III

Biomarkers: MSH2 mutation, dMMR/MSI-H

Postoperative pathology after her 2024 treatment showed no evidence of disease.

Fight Colorectal CancerRead more →

Colorectal Cancer: Nadia's Survivor Story

Patient Info: Nadia D., Female

Nadia is living after surgery for low rectal cancer with a permanent ileostomy, improved quality of life, and ongoing ostomy adaptation.

The Patient StoryRead more →

Young woman with familial adenomatous polyposis and metastatic colorectal cancer

Patient Info: Anonymized, Female, Under 40 | Stage IV

Metastatic Site: left ovary

She completed 12 rounds of FOLFOX and was doing well during ongoing follow-up with imaging and laboratory monitoring.

PubMed CentralRead more →

Stage II Colorectal Cancer: Maggie's Survivor Story

Patient Info: Maggie | Stage II

Diagnosed in September 2024 and declared cancer-free in December 2024 after surgery.

Our Cancer StoriesRead more →

Stage III Colorectal Cancer: Amy's Survivor Story

Patient Info: Amy, Female, Under 40 | Stage III

Biomarkers: Lynch syndrome

As of April 2023, Amy had no evidence of disease after Stage IIIB Lynch syndrome-associated colorectal cancer treatment, with clear scans/tumor-residue testing and ongoing Lynch syndrome surveillance.

The Patient StoryRead more →

Stage II Ascending Colon Cancer Among Five Synchronous Gastrointestinal Cancers

Patient Info: Anonymized, male, 50s | Stage II

Six years after the operation, he remained without recurrence or metastasis and continued regular follow-up.

PubMed CentralRead more →

Stage I Transverse Colon Cancer Among Five Synchronous Gastrointestinal Cancers

Patient Info: Anonymized, male, 50s | Stage I

Six years after the operation, he remained without recurrence or metastasis and continued regular follow-up.

PubMed CentralRead more →

Stage III Rectal Cancer Among Five Synchronous Gastrointestinal Cancers

Patient Info: Anonymized, male, 50s | Stage III

Six years after surgery and adjuvant treatment, he remained without recurrence or metastasis and continued regular follow-up.

PubMed CentralRead more →